UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE...
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company") today announces recent scientific updates and corporate developments...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q...
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health") or (the "Company") today announced that it has entered into a strategic partnership with...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A Amendment No...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number:...
Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or the โCompany") today announced the appointment of Edward Rollins to its Board of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 &nbs...
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company") today announced the appointment of Joseph C. Peters to its Board of...
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health") or (the "Company") today announced the appointment of Steven R. Steinhubl, M.D. as...
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company") today announced the appointment of Tony van Bijleveld as an independent...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.